Valuation: Proteome Sciences plc

Market Cap 6.84M 9.16M 8.01M 7.4M 12.88M 880M 13.11M 88.28M 34.64M 431M 34.42M 33.66M 1.48B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 21.83M 29.25M 25.56M 23.63M 41.11M 2.81B 41.85M 282M 111M 1.38B 110M 107M 4.74B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.91%
Yield 2024 *
-
Yield 2025 -
1 week+39.29%
Current month+18.18%
1 month+25.81%
3 months+23.81%
6 months-39.06%
Current year-22.00%
1 week 1.3
Extreme 1.3
2.16
1 month 1.3
Extreme 1.3
2.3
Current year 1.2
Extreme 1.2
4.4
1 year 1.2
Extreme 1.2
4.4
3 years 1.2
Extreme 1.2
8.71
5 years 1.2
Extreme 1.2
8.79
10 years 1.2
Extreme 1.2
20.25
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap.
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
06/04/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+39.29%-35.86%-74.26% 9.16M
+1.52%-5.83%-31.84%-16.23% 155B
+3.04%-0.48%-8.52%-5.87% 102B
+0.35%-2.20%+2.75%+57.57% 58.81B
-0.94%+5.94%+39.64%+55.35% 52.82B
+3.89%+4.11%-12.09%-38.92% 41.51B
+3.14%-0.97% - - 32.69B
+0.97%+1.30%-11.51%-45.42% 28.6B
-0.57%+0.60%+60.95%-7.25% 25.27B
+2.60%+2.23%-6.41%-6.21% 20.34B
Average +1.41%-3.02%-0.32%-9.03% 51.65B
Weighted average by Cap. +1.66%-4.32%-6.13%-0.06%

Financials

2024 2025
Net sales 4.89M 6.55M 5.72M 5.29M 9.2M 629M 9.37M 63.08M 24.75M 308M 24.59M 24.05M 1.06B 3.76M 5.03M 4.4M 4.07M 7.07M 483M 7.2M 48.48M 19.02M 237M 18.9M 18.48M 815M
Net income -3.41M -4.56M -3.99M -3.69M -6.41M -438M -6.53M -43.96M -17.25M -215M -17.14M -16.76M -739M -3.06M -4.1M -3.58M -3.31M -5.76M -394M -5.87M -39.51M -15.5M -193M -15.4M -15.06M -664M
Net Debt 13.39M 17.95M 15.68M 14.5M 25.22M 1.72B 25.68M 173M 67.83M 844M 67.41M 65.92M 2.91B 14.99M 20.08M 17.55M 16.22M 28.23M 1.93B 28.74M 193M 75.91M 945M 75.43M 73.77M 3.25B
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
14/07/26 GBX 1.950 0.00% 52,017
13/07/26 GBX 1.950 +14.71% 321,456
10/07/26 GBX 1.700 0.00% 85,676
09/07/26 GBX 1.700 -13.71% 287,562
08/07/26 GBX 1.970 +40.71% 1,156,181